Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Mar 31, 2025 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | (Q2)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -2.74%5.65B | 1.11%5.81B | 0.08%1.38B | -4.53%1.4B | 3.18%1.52B | 5.77%1.51B | 5.99%5.74B | 0.95%1.38B | 11.91%1.46B | 4.34%1.48B |
| Cost of revenue | -1.43%4.29B | -0.78%4.35B | 0.47%1.07B | -3.92%1.06B | -0.14%1.14B | 0.49%1.09B | 7.95%4.39B | 2.69%1.06B | 11.23%1.1B | 9.10%1.15B |
| Gross profit | -6.69%1.35B | 7.23%1.45B | -1.24%313.01M | -6.38%342.98M | 14.62%379.72M | 22.62%416.36M | 0.10%1.35B | -4.47%316.92M | 14.01%366.36M | -9.35%331.28M |
| Operating expense | -1.10%1.55B | 0.36%1.57B | -0.58%395.79M | -5.85%375.12M | 7.70%400.74M | 0.65%396.35M | -0.21%1.56B | -1.68%398.11M | 4.02%398.41M | -4.44%372.1M |
| Staff costs | -1.25%863.54M | -3.04%874.52M | ---- | ---- | ---- | ---- | -3.72%901.96M | ---- | ---- | ---- |
| Selling and administrative expenses | -1.72%257.38M | -0.79%261.89M | ---- | ---- | ---- | ---- | 7.79%263.97M | ---- | ---- | ---- |
| -Selling and marketing expense | 19.01%55.51M | -17.81%46.64M | ---- | ---- | ---- | ---- | -0.93%56.74M | ---- | ---- | ---- |
| -General and administrative expense | -6.21%201.87M | 3.87%215.25M | ---- | ---- | ---- | ---- | 10.46%207.22M | ---- | ---- | ---- |
| Research and development costs | 14.54%89.55M | 65.74%78.19M | ---- | ---- | ---- | ---- | -6.74%47.17M | ---- | ---- | ---- |
| Depreciation and amortization | -0.20%71.61M | 0.01%71.75M | ---- | ---- | ---- | ---- | -8.26%71.74M | ---- | ---- | ---- |
| -Depreciation | -0.20%71.61M | 0.01%71.75M | ---- | ---- | ---- | ---- | -8.26%71.74M | ---- | ---- | ---- |
| Rent and land expenses | 0.61%47.56M | -4.60%47.27M | ---- | ---- | ---- | ---- | 3.88%49.55M | ---- | ---- | ---- |
| Other operating expenses | -5.64%221.18M | 2.79%234.39M | ---- | ---- | ---- | ---- | 9.85%228.03M | ---- | ---- | ---- |
| Operating profit | -68.93%-195.83M | 44.35%-115.92M | -1.97%-82.79M | -0.26%-32.14M | 48.52%-21.01M | 136.91%20.02M | 2.17%-208.29M | -10.94%-81.19M | 48.03%-32.06M | -70.63%-40.82M |
| Net non-operating interest income (expenses) | 9.65%8.19M | -5.01%7.47M | 26.20%1.71M | -22.59%1.76M | -15.01%1.77M | 3.58%2.23M | 0.01%7.86M | -23.79%1.36M | 4.13%2.27M | 11.44%2.09M |
| Non-operating interest income | 9.65%8.19M | -5.01%7.47M | 26.20%1.71M | -22.59%1.76M | -15.01%1.77M | 3.58%2.23M | -1.98%7.86M | -28.12%1.36M | 15.87%2.27M | 9.51%2.09M |
| Net investment income | -20.54%31.18M | 214.35%39.25M | 603.18%4.75M | 33.39%15.6M | 100.92%130K | 18.30%18.77M | 15.90%12.49M | 68.91%-944K | -25.81%11.69M | -95.35%-14.13M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -94.36%4.47M | 160.95%79.19M | 98.37%-808K | 72.37%-489K | 201.75%80.49M | 0 | -33,046.68%-129.94M | -15,859.35%-49.47M | -2,541.79%-1.77M | -7,910,200.00%-79.1M |
| Less:Other special charges | 94.36%-4.47M | -196.29%-79.19M | -54.61%808K | -72.37%489K | ---- | ---- | 20,879.85%82.24M | 474.19%1.78M | 2,541.79%1.77M | 7,910,200.00%79.1M |
| Less:Write off | ---- | --0 | ---- | ---- | ---- | ---- | --47.69M | ---- | ---- | ---- |
| Other non-operating income (expenses) | -18.18%51.64M | -0.91%63.11M | 0.42%40.17M | -106.15%-465K | -7.14%11.8M | 239.70%11.6M | 148.30%63.69M | 221.39%40M | 157.40%7.57M | 126.52%12.71M |
| Income before tax | -237.30%-100.36M | 128.75%73.09M | 59.04%-36.97M | -27.98%-15.74M | 161.36%73.18M | 262.46%52.62M | -50.39%-254.19M | -44.86%-90.25M | 69.90%-12.3M | -403.79%-119.26M |
| Income tax | 37.83%21.25M | 497.09%15.42M | 2.58%-10.31M | 13.46%7.95M | 544.03%10.26M | 275.15%7.52M | -139.28%-3.88M | -108.76%-10.58M | 83.26%7.01M | -133.27%-2.31M |
| Net income | -310.84%-121.6M | 123.04%57.68M | 66.54%-26.66M | -22.70%-23.69M | 153.80%62.92M | 231.13%45.1M | -39.91%-250.31M | -39.19%-79.66M | 56.79%-19.31M | -281.97%-116.95M |
| Net income continuous operations | -310.84%-121.6M | 123.04%57.68M | 66.54%-26.66M | -22.71%-23.69M | 153.80%62.92M | 231.13%45.1M | -39.91%-250.31M | -39.19%-79.66M | 56.80%-19.31M | -281.99%-116.95M |
| Noncontrolling interests | 57.67%-13.76M | 47.02%-32.49M | 44.04%-13.84M | -332.16%-7.63M | 87.09%-3.62M | -9.38%-7.4M | -317.60%-61.33M | -329.62%-24.73M | 72.62%-1.77M | -1,146.38%-28.06M |
| Net income attributable to the company | -219.60%-107.85M | 147.71%90.17M | 76.67%-12.82M | 8.46%-16.06M | 174.87%66.54M | 289.99%52.5M | -15.08%-188.98M | -6.71%-54.93M | 54.12%-17.54M | -166.93%-88.88M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -219.60%-107.85M | 147.71%90.17M | 76.67%-12.82M | 8.46%-16.06M | 174.87%66.54M | 289.99%52.5M | -15.08%-188.98M | -6.71%-54.93M | 54.12%-17.54M | -166.93%-88.88M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -219.60%-78.34 | 147.71%65.5 | 76.67%-9.31 | 8.55%-11.66 | 174.88%48.34 | 289.99%38.13 | -15.08%-137.28 | -6.71%-39.9 | 54.10%-12.75 | -166.89%-64.56 |
| Diluted earnings per share | -219.60%-78.34 | 147.71%65.5 | 76.67%-9.31 | 8.51%-11.6646 | 174.87%48.337 | 289.99%38.13 | -15.08%-137.28 | -6.71%-39.9007 | 54.10%-12.75 | -166.90%-64.5624 |
| Dividend per share | 0.00%50 | 0.00%50 | 0.00%50 | 0 | 0 | 0 | 0.00%50 | 0.00%50 | 0 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |